Clinical trial
75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
NCT00140465 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00140465 |
|---|---|
| Title | 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2) |
| Official title | A Double-Blind, Randomized Comparison Between Two Different Clopidogrel Maintenance Doses After Percutaneous Coronary Intervention (ISAR-CHOICE-2) |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Collaborators | Technical University of Munich |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Drug |
| Interventions | Clopidogrel |
| Enrollment | 60 |
| Start date | Oct 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Nov 14, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: